NCT02705716已完成不适用
Short Term Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 409
- 试验地点
- 4
- 主要终点
- Change From Baseline in Schiff Sensitivity Score on Day 14
研究概览
简要总结
This study will investigate the efficacy of an experimental dentifrice containing 0.454% weight/weight (w/w) stannous fluoride in relieving dentine hypersensitivity (DH) after twice daily brushing, over a 2 week treatment period compared with a standard fluoride dentifrice.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Investigator)
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Demonstrates understanding of the study procedures, restrictions and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form.
- •Participant is male or female aged between 18 and 65 years inclusive.
- •Good general and mental health with, in the opinion of the investigator or medically qualified designee.
- •No clinically significant and relevant abnormalities in medical history or upon oral examination.
- •Absence of any condition that would impact on the participant's safety or well being or affect the individual's ability to understand and follow study procedures and requirements.
- •Self-reported history of dentinal hypersensitivity (DH) lasting more than(>) six months but not > 10 years.
- •Good general oral health, with a minimum of 20 natural teeth.
- •Minimum of 2 accessible non-adjacent teeth (incisors, canines, pre-molars), preferably in different quadrants at screening and minimum of two, non-adjacent accessible teeth (incisors, canines, pre-molars) at baseline.
排除标准
- •Women who are pregnant or breast-feeding .
- •Daily doses of medication/treatments which, in the opinion of the Investigator, could interfere with the perception of pain. Examples of such medications include analgesics, anticonvulsants, antihistamines that cause marked or moderate sedation, sedatives, tranquilisers, anti-depressants, mood-altering and anti-inflammatory drugs.
- •Currently taking antibiotics or has taken antibiotics within two weeks of Baseline.
- •Daily dose of a medication which, in the opinion of the investigator, is causing xerostomia.
- •Presence of kidney disease, hyperoxaluria, or any other condition that may be exacerbated by oxalic acid or oxalate salts.
- •Presence of chronic debilitating disease which, in the opinion of the investigator, could affect study outcomes.
- •Any condition which, in the opinion of the investigator, causes xerostomia.
- •Known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients.
- •Participation in another clinical study (including cosmetic studies) or receipt of an investigational drug within 30 days of the screening visit.
- •Previous participation in this study.
- •Recent history (within the last year) of alcohol or other substance abuse.
- •Dental prophylaxis within four weeks of Screening, tongue or lip piercing or presence of dental implants.
- •Desensitizing treatment within eight weeks of Screening (professional sensitivity treatments and non-toothpaste sensitivity treatments).
- •Gross periodontal disease, treatment of periodontal disease (including surgery) within 12 months of Screening, scaling or root planning within 3 months of Screening.
- •Teeth bleaching within eight weeks of Screening.
- •Tooth with evidence of current or recent caries, or reported treatment of decay within 12 months of Screening.
- •Tooth with exposed dentine but with deep, defective or facial restorations, teeth used as abutments for fixed or removable partial dentures, teeth with full crowns or veneers, orthodontic bands or cracked enamel. Sensitive teeth with contributing aetiologies other than erosion, abrasion or recession of exposed dentine.
- •Sensitive tooth not expected to respond to treatment with an over-the-counter toothpaste in the opinion of the Investigator.
- •Use of an oral care product indicated for the relief of dentine hypersensitivity within eight weeks of screening.
- •Individuals who require antibiotic prophylaxis for dental procedures.
- •Any participant who, in the judgment of the investigator, should not participate in the study.
结局指标
主要结局
Change From Baseline in Schiff Sensitivity Score on Day 14
时间窗: Baseline, Day 14
Schiff sensitivity score was assessed by examiner as participant's response to an evaporative (air) stimulus after the stimulation of each individual tooth. Response of participant was scored using Schiff sensitivity scale range of 0-3; 0=Participant does not respond to air stimulation; 1=Participant responds to air stimulus but does not request discontinuation of stimulus; 2=Participant responds to air stimulus and requests discontinuation or moves from stimulus; 3= Participant responds to stimulus, considers stimulus to be painful, and requests discontinuation of the stimulus. A reduction in Schiff Sensitivity score indicates improvement in sensitivity.
次要结局
- Change From Baseline in Schiff Sensitivity Score on Day 7(Baseline, Day 7)
- Change From Baseline in Tactile Threshold on Day 7 and 14(Baseline, Day 7 and Day 14)
研究者
研究点 (4)
Loading locations...
相似试验
已完成
不适用
A Clinical Study Investigating the Effects of a Dentifrice Containing 0.454% Stannous Fluoride on Gingivitis Treatment and Plaque Reduction When Used Twice Daily for 12 WeeksGingivitisNCT06143670HALEON159
已完成
不适用
A Clinical Study to Examine the Effects of an Experimental Toothpaste Compared to a Regular Fluoride Toothpaste on Breath Odor in a Population With GingivitisHalitosisNCT05524948HALEON104
已完成
不适用
A Study Assessing the Effects of an Experimental Dentifrice in Maintaining Tooth Color Following Tooth BleachingDentin SensitivityOral HygieneNCT06150573HALEON160
已完成
4 期
A Clinical Study Assessing the Effects of a Marketed Dentifrice on Tooth Sensitivity While Undergoing Tooth BleachingDentin SensitivityNCT06608368HALEON90
已完成
不适用
A Clinical Study to Evaluate a Stannous Fluoride Toothpaste for the Relief of Dentinal HypersensitivityDentin SensitivityNCT03310268GlaxoSmithKline185